On April 17, various departments such as the Beijing Municipal Medical Security Administration and the Beijing Drug Administration issued “Certain Measures to Support the High-Quality Development of Innovative Pharmaceuticals in Beijing (2024)” to promote the deep integration of innovation chains, industrial chains and policy chains to strengthen the research, production, review, and use of full-chain policies to support the optimization of factor resource allocation, cultivate a high-quality innovation ecosystem, and accelerate innovation in the medical and health industry.
4月17日北京市医疗保障局、北京市药品监督管理局等多部门发布《北京市支持创新医药高质量发展若干措施（2024年）》以推进创新链、产业链和政策链深度融合加强创新药械研、产、审、用全链条政策支持优化要素资源配置培育优质创新生态加速医药健康产业创新。
On April 17, various departments such as the Beijing Municipal Medical Security Administration and the Beijing Drug Administration issued “Certain Measures to Support the High-Quality Development of Innovative Pharmaceuticals in Beijing (2024)” to promote
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.